Volume 4, Issue 4, Pages (April 1996)

Slides:



Advertisements
Similar presentations
Volume 15, Issue 2, Pages (August 2001)
Advertisements

Volume 5, Issue 2, Pages (August 1996)
LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Volume 24, Issue 5, Pages (May 2006)
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide by Yoshinori Nagai, Rintaro Shimazu, Hirotaka.
Volume 13, Issue 5, Pages (November 2000)
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Volume 5, Issue 3, Pages (September 1996)
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 5, Pages (November 1999)
Volume 8, Issue 4, Pages (April 1998)
Volume 5, Issue 4, Pages (October 1996)
Volume 11, Issue 4, Pages (October 1999)
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Volume 9, Issue 4, Pages (October 1998)
Balthazar B Cazac, Jürgen Roes  Immunity 
Volume 9, Issue 3, Pages (September 1998)
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 5, Issue 5, Pages (November 1996)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
Chuxia Deng, Anthony Wynshaw-Boris, Fen Zhou, Ann Kuo, Philip Leder 
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 9, Issue 6, Pages (December 1998)
CD22 is a negative regulator of B-cell receptor signalling
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Volume 93, Issue 5, Pages (May 1998)
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Volume 13, Issue 4, Pages (October 2000)
Volume 17, Issue 1, Pages (July 2002)
Volume 4, Issue 2, Pages (February 1996)
Volume 5, Issue 3, Pages (September 1996)
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Both E12 and E47 Allow Commitment to the B Cell Lineage
Subunit Composition of Kainate Receptors in Hippocampal Interneurons
Volume 6, Issue 3, Pages (March 1997)
Volume 10, Issue 1, Pages (January 1999)
Volume 8, Issue 4, Pages (October 2003)
Volume 4, Issue 3, Pages (March 1996)
Volume 4, Issue 4, Pages (April 1996)
Volume 16, Issue 5, Pages (May 2002)
Altered Antigen Presentation in Mice Lacking H2-O
Volume 19, Issue 5, Pages (November 2003)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Altered Antigen Presentation in Mice Lacking H2-O
Volume 92, Issue 4, Pages (February 1998)
Volume 24, Issue 3, Pages (March 2006)
CD40, but Not CD40L, Is Required for the Optimal Priming of T Cells and Control of Aerosol M. tuberculosis Infection  Vanja Lazarevic, Amy J Myers, Charles.
Volume 7, Issue 5, Pages (November 1997)
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Volume 16, Issue 3, Pages (March 2002)
Volume 8, Issue 1, Pages (January 1998)
Joan E Durbin, Renée Hackenmiller, M.Celeste Simon, David E Levy  Cell 
Volume 10, Issue 4, Pages (April 1999)
TRAF1 Is a Negative Regulator of TNF Signaling
Volume 11, Issue 3, Pages (September 1999)
Volume 4, Issue 3, Pages (September 2008)
Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts  Junjie Mei, Xingxu Huang, Pumin Zhang 
Volume 9, Issue 3, Pages (September 1998)
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Volume 94, Issue 2, Pages (July 1998)
Volume 4, Issue 2, Pages (February 1996)
Volume 24, Issue 1, Pages (January 2006)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
A Stage-Specific Enhancer of Immunoglobulin J Chain Gene Is Induced by Interleukin-2 in a Presecretor B Cell Stage  Chang-Joong Kang, Colleen Sheridan,
Volume 4, Issue 5, Pages (May 1996)
Volume 13, Issue 21, Pages (October 2003)
Control of B Cell Production by the Adaptor Protein Lnk
Presentation transcript:

Volume 4, Issue 4, Pages 407-414 (April 1996) Resistance to Endotoxin Shock and Reduced Dissemination of Gram-Negative Bacteria in CD14-Deficient Mice  Alain Haziot, Enza Ferrero, Frank Köntgen, Naoki Hijiya, Shunsuke Yamamoto, Jack Silver, Colin L Stewart, Sanna M Goyert  Immunity  Volume 4, Issue 4, Pages 407-414 (April 1996) DOI: 10.1016/S1074-7613(00)80254-X

Figure 1 Disruption of the CD14 Gene by Homologous Recombination (A) Map of the CD14 SstI genomic fragment, of the targeting construct, and of the predicted disrupted gene. Closed boxes denote the CD14 exons. The first exon contains the ATG translation start site. The neo box represents the pgk-driven poly(A)− neo gene. The tk box represents the herpes simplex virus–thymidine kinase gene. The thick line represents genomic DNA sequences; the thin line represents plasmid DNA sequences. The restriction enzyme abbreviations are as follows: X, XhoI; Sa, SalI; S, SstI; E, EcoRI; B, BamHI; Nc, NcoI; No, NotI. The 3′ flanking SstI–EcoRI CD14 genomic fragment was used as a probe in Southern blot hybridizations. (B) Southern blot analysis of mouse tail DNA. Genomic DNA was isolated from mouse tails, digested with EcoRI, electrophoresed and hybridized with the CD14 genomic SstI–EcoRI probe. Lane 1, heterozygous; lane 2, wild-type; lane 3, homozygous mutation. Size markers are indicated on the left. (C) Expression of CD14 by peritoneal macrophages of control (top) and CD14-deficient (bottom) mice. Peritoneal macrophages were recovered by peritoneal lavage, blocked with a human Fc fragment (5 μg/5 × 105 cells; Capell, West Chester, Pennsylvania), and stained by indirect immunofluorescence with the anti-mouse CD14 monoclonal antibody rmC5-3 (Matsuura et al. 1994) or an isotype-matched control (IgG1) followed by fluorescein isothiocyanate–labeled goat-anti-rat IgG (Boehringer Mannheim, Indianapolis, Indiana). Analysis was performed on a Profile (Coulter) cytofluorometer. Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 1 Disruption of the CD14 Gene by Homologous Recombination (A) Map of the CD14 SstI genomic fragment, of the targeting construct, and of the predicted disrupted gene. Closed boxes denote the CD14 exons. The first exon contains the ATG translation start site. The neo box represents the pgk-driven poly(A)− neo gene. The tk box represents the herpes simplex virus–thymidine kinase gene. The thick line represents genomic DNA sequences; the thin line represents plasmid DNA sequences. The restriction enzyme abbreviations are as follows: X, XhoI; Sa, SalI; S, SstI; E, EcoRI; B, BamHI; Nc, NcoI; No, NotI. The 3′ flanking SstI–EcoRI CD14 genomic fragment was used as a probe in Southern blot hybridizations. (B) Southern blot analysis of mouse tail DNA. Genomic DNA was isolated from mouse tails, digested with EcoRI, electrophoresed and hybridized with the CD14 genomic SstI–EcoRI probe. Lane 1, heterozygous; lane 2, wild-type; lane 3, homozygous mutation. Size markers are indicated on the left. (C) Expression of CD14 by peritoneal macrophages of control (top) and CD14-deficient (bottom) mice. Peritoneal macrophages were recovered by peritoneal lavage, blocked with a human Fc fragment (5 μg/5 × 105 cells; Capell, West Chester, Pennsylvania), and stained by indirect immunofluorescence with the anti-mouse CD14 monoclonal antibody rmC5-3 (Matsuura et al. 1994) or an isotype-matched control (IgG1) followed by fluorescein isothiocyanate–labeled goat-anti-rat IgG (Boehringer Mannheim, Indianapolis, Indiana). Analysis was performed on a Profile (Coulter) cytofluorometer. Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 1 Disruption of the CD14 Gene by Homologous Recombination (A) Map of the CD14 SstI genomic fragment, of the targeting construct, and of the predicted disrupted gene. Closed boxes denote the CD14 exons. The first exon contains the ATG translation start site. The neo box represents the pgk-driven poly(A)− neo gene. The tk box represents the herpes simplex virus–thymidine kinase gene. The thick line represents genomic DNA sequences; the thin line represents plasmid DNA sequences. The restriction enzyme abbreviations are as follows: X, XhoI; Sa, SalI; S, SstI; E, EcoRI; B, BamHI; Nc, NcoI; No, NotI. The 3′ flanking SstI–EcoRI CD14 genomic fragment was used as a probe in Southern blot hybridizations. (B) Southern blot analysis of mouse tail DNA. Genomic DNA was isolated from mouse tails, digested with EcoRI, electrophoresed and hybridized with the CD14 genomic SstI–EcoRI probe. Lane 1, heterozygous; lane 2, wild-type; lane 3, homozygous mutation. Size markers are indicated on the left. (C) Expression of CD14 by peritoneal macrophages of control (top) and CD14-deficient (bottom) mice. Peritoneal macrophages were recovered by peritoneal lavage, blocked with a human Fc fragment (5 μg/5 × 105 cells; Capell, West Chester, Pennsylvania), and stained by indirect immunofluorescence with the anti-mouse CD14 monoclonal antibody rmC5-3 (Matsuura et al. 1994) or an isotype-matched control (IgG1) followed by fluorescein isothiocyanate–labeled goat-anti-rat IgG (Boehringer Mannheim, Indianapolis, Indiana). Analysis was performed on a Profile (Coulter) cytofluorometer. Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 2 Lethality Induced by LPS in CD14-Deficient Mice Mice (5 per group) were injected intraperitoneally with the indicated doses of LPS from S. minnesota in 0.2 ml nonpyrogenic saline. LD100 doses of LPS were predetermined in separate experiments. All deaths occurred within 72 hr. A second similar experiment gave identical results. Triangles, CD14-deficient 20 mg/kg; squares, CD14-deficient 200 mg/kg; circles, control 20 mg/kg. Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 3 Serum Concentrations of Cytokines in CD14-Deficient Mice Injected with LPS Mice (3 per group) were injected intraperitoneally with 20 or 200 mg/kg LPS (S. minnesota) and were bled from the tail vein at the times indicated. TNFα (A) and IL-6 (B) concentrations were determined by bioassay and ELISA, respectively. Results are represented as mean value ± SEM in each group. Triangles, CD14-deficient 20 mg/kg; squares, CD14-deficient 200 mg/kg; circles, control 20 mg/kg. Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 4 Production of Cytokines Induced by LPS from CD14-Negative and Control PBMC Cells were isolated by density gradient centrifugation and incubated with various concentrations of LPS. TNFα (A) and IL-6 (B) concentrations were determined by bioassay and ELISA, respectively. Closed squares, CD14-deficient; open circles, control. Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 5 Production of Cytokines Induced by sCD14 and LPS from CD14-Negative and Control PBMC PBMC (A) and thioglycollate-elicited peritoneal macrophages (B) from C57BL/6J and CD14-deficient mice were incubated with rsCD14 (20 μg/ml) and various concentrations of LPS (Haziot et al. 1995) in medium supplemented with 1% autologous serum. TNFα concentrations (A) in cell-free supernatants were determined by bioassay (Haziot et al. 1993a) and IL-1β production (B) was determined in cell lysates (Kitchens et al. 1992) by ELISA. Open squares, CD14-deficient; closed squares, CD14-deficient with added rsCD14; open circles, control C57BL/6J. Results shown are representative of two independent experiments. Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 6 Resistance of CD14-Deficient Mice to Bacterially Induced Shock (A) Lethality after Gram-negative infection. Mice were infected intraperitoneally with the indicated number of cfu of E. coli 0111:B4. All deaths occurred within 48 hr following infection and the condition of the surviving mice was monitored for 21 days. Numbers above the bars indicate number of survivors/number of mice in group. (B, C) Serum concentrations of TNFα and IL-6 in E. coli-infected mice. Mice were injected intraperitoneally with E. coli (n = 4) and cytokines were measured in peripheral blood 7 hr after injection. TNFα and IL-6 were measured by bioassay (2) and by ELISA (Endogen), respectively. Results are represented as mean ± SEM in each group. p < 0.05 (Mann-Whitney test). Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 7 Serum Concentrations of TNFα and IL-6 in E. coli-Infected Mice Mice were injected intravenously with E. coli (3 × 107 cfu/mouse, n = 3) and cytokines were measured in peripheral blood as described above. Closed squares, CD14-deficient; open circles, control. Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)

Figure 8 Blood and Organ Counts of Bacteria in E. coli-Infected Mice Bacterial counts were determined 7 hr after intraperitoneal infection with (A) 5 × 106 cfu (4 mice per group), (B) 3 × 107 cfu (4 mice per group), and (C) 3 × 107 cfu (3 mice per group) of E. coli 0111:B4. The number of cfu in blood (A and B) and lung (C) were determined as described in Experimental Procedures. Results are represented as mean ± SEM in each group. p < 0.05 (Mann-Whitney test). Immunity 1996 4, 407-414DOI: (10.1016/S1074-7613(00)80254-X)